These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 913026)

  • 1. Oxidative drug metabolism and inducibility by phenobarbital in sickle cell anemia.
    Anderson KE; Peterson CM; Alvares AP; Kappas A
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):580-7. PubMed ID: 913026
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of age and sex on human drug metabolism.
    O'Malley K; Crooks J; Duke E; Stevenson IH
    Br Med J; 1971 Sep; 3(5775):607-9. PubMed ID: 5569980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of human drug metabolism by oral contraceptive steroids.
    O'Malley K; Stevenson IH; Crooks J
    Clin Pharmacol Ther; 1972; 13(4):552-7. PubMed ID: 5042369
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
    Vesell ES; Page JG
    J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of drugs in rabbits with experimental acute renal failure.
    Van Peer A; Belpaire F; Bogaert M
    Pharmacology; 1978; 17(6):307-14. PubMed ID: 733890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of drug metabolism in the isolated perfused liver and in vivo in rats.
    von Bahr C; Alexanderson B; Azarnoff DL; Sjoqvist F; Orrenius S
    Eur J Pharmacol; 1970 Jan; 9(1):99-105. PubMed ID: 5434299
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug metabolism in normal children, lead-poisoned children, and normal adults.
    Alvares AP; Kapelner S; Sassa S; Kappas A
    Clin Pharmacol Ther; 1975 Feb; 17(2):179-83. PubMed ID: 804369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of aryl hydrocarbon hydroxylase activity of human lymphocyte cultures and plasma elimination rates for antipyrine and phenylbutazone.
    Kellermann G; Luyten-Kellermann M; Horning M; Stafford M
    Drug Metab Dispos; 1975; 3(1):47-50. PubMed ID: 234834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme induction in sheep: effects of phenobarbital on in vivo and in vitro drug metabolism.
    Shetty SN; Himes JA; Edds GT
    Am J Vet Res; 1972 May; 33(5):935-42. PubMed ID: 4112405
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of phenobarbital steady state levels on antipyrine clearance and distribution in the rat.
    Pei YY; Bialer M; Levy RH
    Biopharm Drug Dispos; 1986; 7(1):11-9. PubMed ID: 3955196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral contraceptives on plasma clearance.
    Carter DE; Bressler R; Hughes MR; Haussler MR; Christian D; Heine MW
    Clin Pharmacol Ther; 1975 Dec; 18(6):700-7. PubMed ID: 173489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 14C-antipyrine as a model compound in the study of drug oxidation and enzyme induction in individual surviving rats.
    Bakke OM; Bending M; Aarbakke J; Davies DS
    Acta Pharmacol Toxicol (Copenh); 1974 Aug; 35(2):91-7. PubMed ID: 4479350
    [No Abstract]   [Full Text] [Related]  

  • 14. Application of clearance concepts to some literature data on drug metabolism in the isolated perfused liver preparation and in vivo.
    Rowland M
    Eur J Pharmacol; 1972 Mar; 17(3):352-6. PubMed ID: 5022150
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in rabbits with experimental renal failure.
    van Peer AP; Belpaire FM; Bogaert MG
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):346-7. PubMed ID: 708161
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of hepatic drug oxidation and its relationship to individual differences in rates of oxidation in man.
    Davies DS; Thorgeirsson SS
    Ann N Y Acad Sci; 1971 Jul; 179():411-20. PubMed ID: 5285386
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in uraemic rabbits.
    Van Peer AP; Belpaire FM; Bogaert MG
    J Pharm Pharmacol; 1980 Feb; 32(2):135-6. PubMed ID: 6103036
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug metabolism in a geriatric population.
    O'Malley K; Stevenson IH; Crooks J
    Clin Sci; 1971 Aug; 41(2):6P. PubMed ID: 5564320
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic control of drug levels and of the induction of drug-metabolizing enzymes in man: individual variability in the extent of allopurinol and nortriptyline inhibition of drug metabolism.
    Vesell ES; Passananti GT; Greene FE; Page JG
    Ann N Y Acad Sci; 1971 Jul; 179():752-73. PubMed ID: 4105797
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic control of drug levels in man: antipyrine.
    Vesell ES; Page JG
    Science; 1968 Jul; 161(3836):72-3. PubMed ID: 5690279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.